Shares of BioPharma Credit PLC (OTCMKTS:BOPCF – Get Free Report) traded down 2.3% on Tuesday . The company traded as low as $0.9546 and last traded at $0.9576. 666 shares changed hands during mid-day trading, a decline of 100% from the average session volume of 398,644 shares. The stock had previously closed at $0.98.
BioPharma Credit Stock Performance
The firm has a 50 day moving average price of $0.95 and a 200-day moving average price of $0.91.
BioPharma Credit Company Profile
BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.
Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms.
Featured Stories
- Five stocks we like better than BioPharma Credit
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
